http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#Head
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#assertion
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#provenance
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#pubinfo
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#assertion
http://purl.obolibrary.org/obo/DOID_1067
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1067
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00287
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
http://www.w3.org/2000/01/rdf-schema#label
travoprost ophthalmic solution usp 4 is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension travoprost ophthalmic solution usp 4 is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension 1
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB00287
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#provenance
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#pubinfo
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#sig
http://purl.org/nanopub/x/hasSignature
a4whmOO7PxlvztZW4Dp2PDKS+ir19zz6ghYKS2KwtAazeBLBdy9qyhxupwYqzxMrO1cqyBTmQ4tZRr46oNFl93ROhududr77d8WK8jIjEAvXnTksWtC4RQZo2mxIy22sNzHz7WEfPJk551zjdAEsNsdd+ZZRdIqkTAerXIQ5pOs=
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://purl.org/dc/terms/created
2021-07-03T13:17:29.578+02:00
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAIiNlCZr-W0lUpNj3vXFXor4U3y4mwtCJ_gPyF1rbjfo
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs